Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Kala’s dry eye disease candidate KPI-121 meets objective in STRIDE 3 trial

pharmaceutical-business-reviewMarch 12, 2020

Tag: Kala Pharmaceuticals , Dry Eye Disease , KPI-121

PharmaSources Customer Service